Morepen Laboratories Limited
Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
What Morepen files
- Others58
- Important37
- Updates32
- Investor Meet9
- Board Meeting8
- PPTs6
Morepen Laboratories has set September 19, 2026, as the record date. This is to identify shareholders eligible for the final dividend for the financial year ending March 31, 2026. The dividend payout is contingent upon shareholder approval at the upcoming 41st Annual General Meeting, which is scheduled for September 26,...
Morepen Labs' board has proposed a final dividend of Re 0.20 per equity share (FV Rs 2) for FY26, pending shareholder approval. A significant business update includes revising the effective date for its Medical Devices business slump sale to subsidiary Morepen Medipath to April 1, 2026. This transfer, delayed by...
Morepen Labs has fixed August 30, 2025, as the record date. This date determines which shareholders are eligible to receive the final dividend for the financial year ended March 31, 2025. Remember, this dividend payout is contingent on shareholder approval at the company's 40th Annual General Meeting. Keep an eye...
Morepen Laboratories has announced a final dividend of Rs. 0.20 per share (face value Rs. 2) for FY25, pending shareholder approval at the AGM. Note that around 50.63 lakh shares held by fixed deposit holders won’t receive this dividend. The company posted a consolidated net profit of Rs. 118.02 Cr...